TREM2 and Alzheimer disease: Additionally, among the numerous AD risk genes reported, myeloid cell trigger receptor 2 (TREM2) and CD33 primarily act through microglia, and genetic variations in both genes can lead to reduced uptake and clearance of Aβ by microglia [147].